Correlation Between Puma Biotechnology and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Puma Biotechnology and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Syndax Pharmaceuticals.
Diversification Opportunities for Puma Biotechnology and Syndax Pharmaceuticals
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Puma and Syndax is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Syndax Pharmaceuticals
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 1.06 times more return on investment than Syndax Pharmaceuticals. However, Puma Biotechnology is 1.06 times more volatile than Syndax Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 258.00 in Puma Biotechnology on August 28, 2024 and sell it today you would earn a total of 56.00 from holding Puma Biotechnology or generate 21.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Puma Biotechnology vs. Syndax Pharmaceuticals
Performance |
| Timeline |
| Puma Biotechnology |
| Syndax Pharmaceuticals |
Puma Biotechnology and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and Syndax Pharmaceuticals
The main advantage of trading using opposite Puma Biotechnology and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
| Syndax Pharmaceuticals vs. Eliem Therapeutics | Syndax Pharmaceuticals vs. Scpharmaceuticals | Syndax Pharmaceuticals vs. Milestone Pharmaceuticals | Syndax Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |